← Back to generic index

Candesartan Cilexetil — brands & medicines in Pakistan

Pakistan mein Candesartan Cilexetil ke 1 brands available hain. Drug class: Angiotensin II Receptor Blocker. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.

Quick Answer

Candesartan Cilexetil is a angiotensin ii receptor blocker used in Pakistan for High blood pressure (BP high hona), Heart failure (dil kamzor hona), Prevention of stroke in patients with hypertension (BP high hona). Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.

What is Candesartan Cilexetil?

Candesartan Cilexetil is a angiotensin ii receptor blocker used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Candesartan Cilexetil under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.

Common indications

  • High blood pressure (BP high hona)
  • Heart failure (dil kamzor hona)
  • Prevention of stroke in patients with hypertension (BP high hona)
  • Prevention of heart attack in high-risk patients (heart attack se bachao)
  • Kidney protection in diabetic patients with high blood pressure (BP high hona)
  • Doctor-advised cardiovascular care (doctor ke mashware se)

Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.

Typical dosage

As prescribed

This is a general adult guidance pattern based on the manufacturer's label for one of the Candesartan Cilexetil brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.

Side effects

Common (usually mild)

  • Dizziness
  • Headache
  • Back pain

Serious — stop and see a doctor

  • Breathing issue
  • Fainting
  • Severe swelling

Important warnings

  • Don't use Advant Tablet if you are allergic to Candesartan or any ingredients in the tablet
  • Avoid during pregnancy

Candesartan Cilexetil brands in Pakistan (1)

Click any brand to see full uses, dosage, side effects, prices, and warnings.

Frequently asked questions

What is Candesartan Cilexetil used for in Pakistan?

Candesartan Cilexetil is commonly used for High blood pressure (BP high hona), Heart failure (dil kamzor hona), Prevention of stroke in patients with hypertension (BP high hona), Prevention of heart attack in high-risk patients (heart attack se bachao), and other indications. It belongs to the angiotensin ii receptor blocker drug class.

What is the typical dosage of Candesartan Cilexetil?

Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.

What are the common side effects of Candesartan Cilexetil?

Common side effects include Dizziness, Headache, Back pain. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).

When should I stop Candesartan Cilexetil and see a doctor?

Stop Candesartan Cilexetil and seek urgent medical care if you experience: Breathing issue; Fainting; Severe swelling. These are serious signs that need immediate attention.

Is Candesartan Cilexetil available without a prescription in Pakistan?

Prescription required.

What brands of Candesartan Cilexetil are available in Pakistan?

1 brand of Candesartan Cilexetil is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.

Sources

  1. DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
  2. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
  3. WHO Model List of Essential Medicines, 23rd ed. — World Health Organization